Loading viewer...
investor_presentation
Format: PDF investor_presentation
Sernova Corp is a clinical-stage biotech company developing the Cell Pouch System™, an implantable device containing immuno-protected therapeutic cells for treating chronic diseases like type 1 diabetes. The platform aims to deliver a functional cure by enabling cells to produce continuous insulin supply, potentially reducing or eliminating the need for insulin injections.
investor_presentation
25 Pages
Sernova Corp 2022 Investor Presentation Cell Pouch
investor_presentationinvestor_presentation
26 Pages
investor_presentation
45 Pages
Philip Morris International
investor_presentation
Bora Bora Resources